Jeong-Sun Yang

Title: Jeong-Sun Yang: Innovator in SARS-CoV-2 Neutralization

Introduction

Jeong-Sun Yang is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the fight against viral infections. His innovative work has led to the development of a binding molecule that targets SARS-coronavirus-2, the virus responsible for COVID-19.

Latest Patents

Yang holds a patent for a binding molecule having neutralizing activity against SARS-coronavirus-2. This invention relates to a binding molecule that effectively binds to the spike protein on the surface of SARS-coronavirus-2. The binding molecule demonstrates a strong ability to neutralize the virus, making it highly valuable for the diagnosis, prevention, or treatment of SARS-coronavirus infection.

Career Highlights

Throughout his career, Jeong-Sun Yang has worked with notable organizations, including Celltrion Inc. and the Korea Disease Control and Prevention Agency. His experience in these institutions has allowed him to contribute to significant advancements in public health and biotechnology.

Collaborations

Yang has collaborated with esteemed colleagues such as Ji-Min Seo and Soo-Young Lee. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Jeong-Sun Yang's work in developing a neutralizing binding molecule against SARS-coronavirus-2 showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against COVID-19 and highlight the importance of innovation in public health.